Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5412-5416

  Shaheen, Raymond M ^a   Davis, Darren W ^a   Liu, Wenbiao ^a   Zebrowski, Brian K ^a   Wilson, Michael R ^a   Bucana, Corazon D ^a   McConkey, David J ^a   McMahon, Gerald ^b   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN TYROSINE KINASE INHIBITOR; SEMAXANIB; SU 6688; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; COLON CANCER; DRUG PROTEIN BINDING; DRUG TARGETING; LIVER METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; COLONIC NEOPLASMS; ENDOTHELIUM; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; INDOLES; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PYRROLES; RANDOM ALLOCATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0033231069     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Folkman, J. Angiogenesis in cancer, vascular, rhuematoid and other disease. Nat. Med., 1: 27-31, 1995.
2. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
3. Kumar, R., Yoneda, J., Bucana, C. D., and Fidler, I. J. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int. J. Oncol., 12: 749-757, 1998.
4. Hsu, S., Huang, F., and Friedman, E. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J. Cell, Physiol., 165: 239-245, 1995.
5. Heldin, C. H. Protein tyrosine kinase receptors. Cancer Surv., 27: 7-24, 1996.
6. Leenders, W. P. J. Targeting VEGF in anti-angiogenic and anti-tumour therapy: where are we now? Int. J. Exp. Pathol., 79: 339-346, 1998.
7. Shawver, L. K., Lipson, K. E., Fong, T. A. T., McMahon, G., Plowman, G. D., and Strawn, L. M. Receptor tyrosine kinases as targets for inhibition of angiogenesis. Drug Discovery Today, 2: 50-63, 1997.
8. Fong, T. A., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T. J., Kim, Y. H., Schreck, R., Wang, X., Risau, W., Ullrich, A., Hirth, K. P., and McMahon, G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res., 59: 99-106, 1999.
9. Dong, Z., Radinsky, R., Fan, D., Tsan, R., Bucana, C. D., Wilmanns, C., and Fidler, I. J. Organ-specific modulation of steady-state mdr-1 gene expression and drug resistance in murine colon cancer cells. J. Natl. Cancer Inst., 86: 913-920, 1994.
10. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 3:65-71, 1992.
11. Bussolino, F., Mantovani, A., and Persico, G. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci., 22: 251-256, 1997.
12. Machein, M. R., Risau, W., and Plate, K. H. Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2. Hum. Gene Ther., 10: 1117-1128, 1999.
13. Mordenti, J., Thomsen, K., Licko, V., Chen, H., Meng, Y. G., and Ferrara, N. Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans. Toxicol. Pathol., 27: 14-21, 1999.
14. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat. Med., 1: 149-153, 1995.
15. Gerber, H. P., Dixit, V., and Ferrara, N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and Al in vascular endothelial cells. J. Biol. Chem., 273: 13313-13316, 1998.